Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles

International Journal of Pharmaceutics

Volumn 387, Issue 1-2, 2010, Pages 272-277

  Thomas, M J K ^a   Slipper, I ^a   Walunj, A ^a   Jain, A ^a   Favretto, M E ^b   Kallinteri, P ^b   Douroumis, D ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Antiepileptic drugs; Cytotoxicity; Loading; Mesoporous silica; SBA 16

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; COPOLYMER; NANOPARTICLE; OXCARBAZEPINE; RUFINAMIDE; SILICATE;

ARTICLE; CELL VIABILITY; CYTOTOXICITY TEST; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG STRUCTURE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; X RAY POWDER DIFFRACTION;

3T3 CELLS; ANIMALS; ANTICONVULSANTS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; FIBROBLASTS; MICE; NANOPARTICLES; PARTICLE SIZE; POLYMERS; POROSITY; SILICON DIOXIDE; SOLUBILITY; TOXICITY TESTS; X-RAY DIFFRACTION;

EID: 77649183265     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.023     Document Type: Article

References (32)

1. Amidon G.L., Löbenberg R. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000, 50:3-12.
2. Amidon G.L., Lunnernas H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12:413-420.
3. Beck J.S., Vartuli J.C., Roth W.J., Leonowicz M.E., Kresge C.T., Schmitt K.D., Chu C.T.-W., Olsen D.H., Sheppard E.W., McCullen S.B., Higgins J.B., Schlenker J.L.J. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 1992, 114:10834-10843.
4. Behme R.J., Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 1991, 80:986-990.
5. Blanco E., Kessinger C.W., Sumer B.D., Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. (Maywood) 2009, 234:123-131.
6. Charnay C., Begu S., Tourne-Peteilh C., Nicole L., Lerner D.A., Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica:drug loading and release property. Eur. J. Pharm. Biopharm. 2004, 57:533-540.
7. Delehanty J.B., Mattoussi H., Medintz I.L. Delivering quantum dots into cells: strategies, progress and remaining issues. Anal. Bioanal. Chem. 2009, 393:1091-1105.
8. Douroumis D., Fahr A. Nano and micro-particulate formulations of poorly water soluble drugs by using a novel optimized technique. Eur. J. Pharm. Biopharm. 2006, 63:173-175.
9. Douroumis D., Fahr A. Formulation and stabilization of Carbamazepine colloidal suspensions. Eur. J. Pharm. Sci. 2007, 30:367-374.
10. Grzesiak A.L., Lang M., Kim K., Adam J., Matzger A.J. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J. Pharm. Sci. 2003, 92:2260-2271.
11. Heikkilä T., Salonen J., Tuura J., Kumar N., Salmi T., Murzin D.Y., Hamdy M.S., Mul G., Laitinen L., Kaukonen A.M., Hirvonen J., Lehto V.-P. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv. 2007, 14:337-347.
12. Huo Q., Margoleses S.I., Ciesla U., Feng U.P., Gier D.E., Sieger P., Leon B.F.R., Petroff P.M., Schuth F., Stucky G.D. Generalized synthesis of periodic surfactant/inorganic composite material. Nature 1994, 368:317-320.
13. Katzhendler I., Azouryb, Friedman R.M. Crystalline properties of carbamazepine in sustained releasehydrophilic matrix tablets based on hydroxypropyl methylcellulose. J. Control. Release 1998, 54:69-85.
14. Kortesuo P., Ahola M., Karlsson S., Kangasniemi I., Yli-Urpo A., Kiesvaara J. Silica xerogel as an implantable carrier for controlled drug delivery-evaluation of drug distribution and tissue effects after implantation. Biomaterials 1999, 21:193-198.
15. Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359:710-712.
16. Lin W.S., Huang Y.W., Zhou X.D., Ma Y.F. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217:252-259.
17. Lin W., Rieter W.J., Taylor K.M. Modular synthesis of functional nanoscale coordination polymers. Angew. Chem. Int. Ed. Engl. 2009, 48:650-658.
18. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
19. Lowes M.M.J., Caira M.R., Lotter A.P., Van Der Watt J.G. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 1987, 76:744-752.
20. Mosmann T. Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Napierska D., Thomassen L.C.J., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., Martens J.A., Hoet P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
22. Polyak B., Friedman G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin. Drug Deliv. 2009, 6:53-70.
23. Qu F., Zhu G., Huang S., Li S., Zhang J.S.D., Qiu S. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Micropor. Mesopor. Mater. 2006, 92:1-9.
24. Ravikovitch P.I., Neimark A.V. Relations between Structural parameters and adsorption characterization of templated nanoporous materials with cubic symmetry. Langmuir 2000, 16:2419-2423.
25. Riikonen J., Mäkilä E., Salonen J., Lehto V.P. Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries. Langmuir 2009, 25:6137-6142.
26. Schiffelers R.M., Storm G. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells. Int. J. Pharm. 2008, 364:258-264.
27. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60:1278-1288.
28. Sperling R.A., Rivera G.P., Zhang F., Zanella M., Parak W.J. Biological applications of gold nanoparticles. Chem. Soc. Rev. 2008, 37:1896-1908.
29. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007, 46:7548-7558.
30. Vallet-Regi M., Ramila A., del Real R.P., Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem. Mater. 2001, 13:308-311.
31. Wen L.X., Ding H.M., Wang J.X., Chen J.F. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine. J. Nanosci. Nanotechnol. 2006, 9-10:3139-3144.
32. Zhao D., Huo Q., Feng J., Chmelka B.F., Stucky G.D. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J. Am. Chem. Soc. 1998, 120:6024-6036.